Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
- DOI
- 10.1200/jco.2013.51.1857
- Published
- 2014 Apr 1
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco.2013.51.1857,
title = {Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.},
author = {Rosmarin D and Palles C and Church D and Domingo E and Jones A and Johnstone E and Wang H and Love S and Julier P and Scudder C and Nicholson G and Gonzalez-Neira A and Martin M and Sargent D and Green E and McLeod H and Zanger UM and Schwab M and Braun M and Seymour M and Thompson L and Lacas B and Boige V and Ribelles N and Afzal S and Enghusen H and Jensen SA and Etienne-Grimaldi MC and Milano G and Wadelius M and Glimelius B and Garmo H and Gusella M and Lecomte T and Laurent-Puig P and Martinez-Balibrea E and Sharma R and Garcia-Foncillas J and Kleibl Z and Morel A and Pignon JP and Midgley R and Kerr D and Tomlinson I},
year = {2014},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco.2013.51.1857},
url = {https://doi.org/10.1200/jco.2013.51.1857}
}RIS
TY - JOUR TI - Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. AU - Rosmarin D AU - Palles C AU - Church D AU - Domingo E AU - Jones A AU - Johnstone E AU - Wang H AU - Love S AU - Julier P AU - Scudder C AU - Nicholson G AU - Gonzalez-Neira A AU - Martin M AU - Sargent D AU - Green E AU - McLeod H AU - Zanger UM AU - Schwab M AU - Braun M AU - Seymour M AU - Thompson L AU - Lacas B AU - Boige V AU - Ribelles N AU - Afzal S AU - Enghusen H AU - Jensen SA AU - Etienne-Grimaldi MC AU - Milano G AU - Wadelius M AU - Glimelius B AU - Garmo H AU - Gusella M AU - Lecomte T AU - Laurent-Puig P AU - Martinez-Balibrea E AU - Sharma R AU - Garcia-Foncillas J AU - Kleibl Z AU - Morel A AU - Pignon JP AU - Midgley R AU - Kerr D AU - Tomlinson I PY - 2014 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco.2013.51.1857 UR - https://doi.org/10.1200/jco.2013.51.1857 ER -
APA
D, R., C, P., D, C., E, D., A, J., E, J., H, W., S, L., P, J., C, S., G, N., A, G., M, M., D, S., E, G., H, M., UM, Z., M, S., M, B., M, S., L, T., B, L., V, B., N, R., S, A., H, E., SA, J., MC, E., G, M., M, W., B, G., H, G., M, G., T, L., P, L., E, M., R, S., J, G., Z, K., A, M., JP, P., R, M., D, K., & I, T. (2014). Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.2013.51.1857
Source records
- pubmed · retrieved 2026-09-26T22:57:05.214Z
- europe-pmc · retrieved 2026-09-26T22:57:05.236Z